EUVIMEDEUVIMED entdecken
Crossref

PD‐L1 and PD‐1 expression in pediatric post‐transplant Burkitt lymphoma and other monomorphic post‐transplant lymphoproliferative disorders

Ashley V Geerlinks, Upton Allen, Bo-Yee Ngan, Angela Punnett iD

Pediatric Blood & Cancer · 2023

DOI: 10.1002/pbc.30674 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2023. Verfasst von Ashley V Geerlinks und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Hematology/Oncology, Children's Hospital, Schulich School of Medicine, Western University, London, Ontario, Canada. Hauptthemen laut MEDLINE: Programmed Cell Death 1 Receptor, B7-H1 Antigen, Burkitt Lymphoma, Lymphoproliferative Disorders. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post‐transplant lymphoproliferative disorders (PTLD) develop as a consequence of immune suppression. Programmed death protein 1 (PD‐1), a regulator of host immune activation, binds to programmed death‐ligand 1 (PD‐L1) to suppress the T‐cell immune response. PD‐1/PD‐L1 pathway may play a role in PTLD. The objective was to describe intratumoral expression of PD‐L1 and PD‐1 in pediatric monomorphic PTLD, and assess if density of these cells is associated with progression‐free survival (PFS) and overall survival (OS). Procedure Clinical variables and outcome data were collected on B‐cell monomorphic PTLD treated in Toronto, Canada between 2000 and 2017. Diagnostic area from tumor tissue was identified to count CD3‐positive or PD‐1‐positive cells and CD3‐negative lymphoma B cells or PD‐L1‐positive cells. CD3 + , PD‐1 + , and PD‐L1 + cell densities were compared between cases of PTLD. OS and PFS were analyzed.

Results

We identified 25 cases of B‐cell monomorphic PTLD; majority Burkitt lymphoma (32%) and diffuse large B‐cell lymphoma (56%). All cases had CD3 + cells infiltrating the tumor, and median percentage of CD3 + cells was 14% (interquartile range: 6.2%–25%). Twelve cases (48%) had PD‐1 + cell infiltrating (range: 1%–83%) and 13 cases (52%) had no PD‐1 + cells infiltrating. Sixteen cases (64%) had PD‐L1 + cells present; however, there was no PD‐L1 expression on any Burkitt lymphoma tissue. When comparing PD‐1 and PD‐L1 expression, there was no difference in OS or PFS.

Conclusion

Intratumoral presence of PD‐1 + and PD‐L1 + cells varied in pediatric patients with monomorphic PTLD; however, no relationship to OS and PFS was identified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Programmed Cell Death 1 ReceptorB7-H1 AntigenBurkitt LymphomaLymphoproliferative DisordersHematopoietic Stem Cell TransplantationHumansChildMaleFemaleChild, PreschoolAdolescentSurvival RateFollow-Up StudiesInfantPrognosisRetrospective Studies

Stichwörter der Autor:innen

Burkitt lymphomaPD-1PD-L1PTLDhistopathology

Substanzen

Programmed Cell Death 1 ReceptorB7-H1 AntigenPDCD1 protein, humanCD274 protein, human

Autor:innen und Institutionen

  • Pediatric Hematology/Oncology, Children's Hospital, Schulich School of Medicine, Western University, London, Ontario, Canada.
  • Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Division of Pathology, Department of Pediatric Laboratory Medicine, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.

ORCID-Profile: Angela Punnett

Zitieren

APA

Geerlinks, A. V., Allen, U., Ngan, B. Y., & Punnett, A. (2023). PD‐L1 and PD‐1 expression in pediatric post‐transplant Burkitt lymphoma and other monomorphic post‐transplant lymphoproliferative disorders. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30674

Vancouver

Geerlinks AV, Allen U, Ngan BY, Punnett A. PD‐L1 and PD‐1 expression in pediatric post‐transplant Burkitt lymphoma and other monomorphic post‐transplant lymphoproliferative disorders. Pediatric Blood & Cancer. 2023. doi:10.1002/pbc.30674

BibTeX
@article{Geerlinks2023,
  author = {Geerlinks, Ashley V and Allen, Upton and Ngan, Bo-Yee and Punnett, Angela},
  title = {PD‐L1 and PD‐1 expression in pediatric post‐transplant Burkitt lymphoma and other monomorphic post‐transplant lymphoproliferative disorders},
  journal = {Pediatric Blood & Cancer},
  year = {2023},
  doi = {10.1002/pbc.30674}
}
Kostenlos starten →